#esmo19 OR #esmo2019, Twitter, 9/29/2019 8:35:02 PM, 211338


FAQ | Problem?

#esmo19 OR #esmo2019 Twitter NodeXL SNA Map and Report for Sunday, 29 September 2019 at 18:27 UTC
#esmo19 OR #esmo2019 Twitter NodeXL SNA Map and Report for Sunday, 29 September 2019 at 18:27 UTC
From:
scotpublichealth
Uploaded on:
September 29, 2019
Short Description:
#esmo19 OR #esmo2019 via NodeXL http://bit.ly/2nLCJqZ
@myesmo
@katsuakimaehara
@nejm
@oncoalert
@andybiotech
@hagsie
@fabioschutz78
@scienceatbms
@breastdocuk
@lizcancerhealth

Top hashtags:
#esmo19
#esmo2019
#oncoalert
#lcsm
#immunotherapy
#cancer
#bcsm
#melanoma

Description:
Description
The graph represents a network of 5,608 Twitter users whose recent tweets contained "#esmo19 OR #esmo2019", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Sunday, 29 September 2019 at 18:45 UTC.

The tweets in the network were tweeted over the 2-day, 2-hour, 22-minute period from Friday, 27 September 2019 at 16:04 UTC to Sunday, 29 September 2019 at 18:26 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 5608
Unique Edges : 17962
Edges With Duplicates : 18803
Total Edges : 36765
Self-Loops : 2563
Reciprocated Vertex Pair Ratio : 0.0503040091202736
Reciprocated Edge Ratio : 0.095789426077518
Connected Components : 228
Single-Vertex Connected Components : 145
Maximum Vertices in a Connected Component : 5236
Maximum Edges in a Connected Component : 36224
Maximum Geodesic Distance (Diameter) : 11
Average Geodesic Distance : 3.597077
Graph Density : 0.000703185365145005
Modularity : 0.339302
NodeXL Version : 1.0.1.419

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[45] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30620-5/fulltext
[28] https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/
[23] https://twitter.com/NEJM/status/1177956124990902273
[21] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[20] https://www.esmo.org/Oncology-News/Nivolumab-Challenges-Sorafenib-as-First-line-Treatment-in-Advanced-HCC?hit=some
[17] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[17] https://www.statnews.com/2019/09/28/astrazeneca-and-gsk-drugs-reduce-risk-of-ovarian-cancer-returning/
[16] https://www.nejm.org/doi/full/10.1056/NEJMoa1910231?query=featured_home&cookieSet=1
[12] https://twitter.com/anacasbal/status/1178205229445255169
[12] http://dailyreporter.esmo.org/nsclc-challenges-of-a-common-cancer-slit-into-subgroups/?hit=some

Top URLs in Tweet in G1:
[8] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[8] https://twitter.com/NEJM/status/1177956124990902273
[8] https://twitter.com/MyelomaEurope/status/1177984470319861761
[7] https://twitter.com/diseaseprimers/status/1177539882337484802
[7] https://twitter.com/LMC_PACIENTES/status/1178344292781301760/photo/1
[6] https://www.siogconference.org/
[6] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[6] https://twitter.com/DrAbhiPal/status/1177875759509184512
[6] https://twitter.com/anacasbal/status/1178205229445255169
[6] https://twitter.com/darioT_/status/1177874588505661445

Top URLs in Tweet in G2:
[20] https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/
[12] https://www.statnews.com/2019/09/28/astrazeneca-and-gsk-drugs-reduce-risk-of-ovarian-cancer-returning/
[11] https://www.esmo.org/Oncology-News/Nivolumab-Challenges-Sorafenib-as-First-line-Treatment-in-Advanced-HCC?hit=some
[11] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-kras-springs-leak
[10] https://www.nejm.org/doi/full/10.1056/NEJMoa1910231?query=featured_home&cookieSet=1
[9] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-lynparza-pushes-parps-forward-again
[9] https://oncologiabrasil.com.br/esmo-19
[8] https://twitter.com/vpavinato/status/1177819166327349248
[8] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30620-5/fulltext
[7] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-too-little-too-late-abbvie-and-veliparib

Top URLs in Tweet in G3:
[13] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[10] https://twitter.com/NEJM/status/1177956124990902273
[7] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[7] https://twitter.com/darioT_/status/1177520767799627776
[6] http://dailyreporter.esmo.org/not-just-for-girls-so-who-else-should-be-vaccinated-for-hpv/?hit=some
[6] http://dailyreporter.esmo.org/nsclc-challenges-of-a-common-cancer-slit-into-subgroups/?hit=some
[5] https://twitter.com/ppsarcomen/status/1177923884139589632
[5] https://www.medscape.org/symposium/thrombosis-registration
[5] https://www.healthtechdigital.com/three-scalp-cooling-abstracts-to-be-presented-at-esmo-2019/
[4] https://doi.org/10.1016/j.iotech.2019.07.001?sf220083143=1

Top URLs in Tweet in G4:
[34] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30620-5/fulltext
[6] https://www.ctu.mrc.ac.uk/news/news-stories/2019/september/more-men-with-prostate-cancer-can-be-spared-radiotherapy-after-surgery/
[5] https://www.thelancet.com/for-authors?utm_campaign=exhibits19&utm_source=twitter&utm_medium=social
[3] https://twitter.com/FabioSchutz78/status/1177844931840401408
[3] https://twitter.com/FabioSchutz78/status/1177574101654888448
[3] https://twitter.com/FabioSchutz78/status/1177559545813639168
[3] http://dailyreporter.esmo.org/prostate-cancer-what-is-the-optimal-timing-for-radiotherapy/
[3] https://www.mdanderson.org/newsroom/parp-inhibitor-plus-chemotherapy-improves-progression-free-survival-for-advanced-ovarian-cancer-patients.h00-159306201.html?cmpid=twitter_newsroom_ovarian_clinicaltrials
[3] https://twitter.com/neerajaiims/status/1158274256653807618
[3] https://twitter.com/fabioschutz78/status/1177839984587530240

Top URLs in Tweet in G5:
[3] https://twitter.com/anacasbal/status/1178205229445255169
[3] https://twitter.com/FabioSchutz78/status/1177574101654888448
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1910836?cookieSet=1
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1910962?cookieSet=1
[2] https://www.esmo.org/Press-Office/Press-Releases/ESMO-Congress-breast-cancer-Monaleesa3-monarch2-Sledge-Slamon
[2] https://www.dana-farber.org/newsroom/news-releases/2019/new-blood-test-capable-of-detecting-multiple-types-of-cancer/
[2] https://www.mdanderson.org/publications/annual-report/annual-report-2017/unraveling-a-complex-disease-with-blood-draw.html?cmpid=twitter_annualreport_science
[2] https://ckbhome.jax.org/
[1] https://www.nejm.org/doi/full/10.1056/NEJMoa1909707
[1] https://www.nejm.org/doi/full/10.1056/NEJMoa1910836

Top URLs in Tweet in G6:
[1] http://www.bms.com/media/media-library/scientific-media-resources/oncology-timeline.html?cid=s_903290
[1] https://twitter.com/BreastDocUK/status/1178310772562317312
[1] https://twitter.com/agrothey/status/1177572609829036032
[1] https://twitter.com/NEJM/status/1177835328993927168
[1] https://www.libtayo.com/advanced-cscc?utm_source=TwitterReg&utm_medium=WebsiteCard3&utm_campaign=ESMO2019&utm_content=Keyword
[1] https://www.libtayo.com/advanced-cscc?utm_source=TwitterReg&utm_medium=WebsiteCard3&utm_campaign=ESMO2019&utm_content=HCPAssociations
[1] https://www.libtayo.com/advanced-cscc?utm_source=TwitterReg&utm_medium=WebsiteCard3&utm_campaign=ESMO2019&utm_content=ESMO
[1] https://www.libtayo.com/advanced-cscc?utm_source=TwitterReg&utm_medium=WebsiteCard3&utm_campaign=ESMO2019&utm_content=Instituitions
[1] https://www.libtayo.com/advanced-cscc?utm_source=TwitterReg&utm_medium=WebsiteCard3&utm_campaign=ESMO2019&utm_content=Outlets
[1] https://www.oncology-central.com/disease-area/gynecologic/esmo-2019-day-1-highlights-checkmate-227-and-checkmate-067-trial-results/

Top URLs in Tweet in G7:
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa1910231?query=featured_home&cookieSet=1
[4] https://www.cancerresearch.org/news/2019/2019-global-immuno-oncology-landscape-report-cri
[4] https://www.nature.com/articles/d41573-019-00167-9
[4] https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/
[3] https://www.loxooncology.com/docs/presentations/LOXO-292_ESMO2019_28EPT2019.pdf
[3] https://www.statnews.com/2019/09/28/astrazeneca-and-gsk-drugs-reduce-risk-of-ovarian-cancer-returning/
[2] https://www.bbc.com/news/health-49853878
[2] https://www.fiercebiotech.com/biotech/g1-shares-data-significant-increase-breast-cancer-survival
[2] https://cancerresearch.org/scientists/clinical-accelerator/landscape-of-immuno-oncology-drug-development
[2] https://www.cancerresearch.org/scientists/immuno-oncology-landscape

Top URLs in Tweet in G8:
[3] https://endpts.com/esmo19-bristol-myers-squibb-boasts-impressive-5-year-melanoma-os-data-on-opdivo-yervoy-combo-though-it-still-cant-pinpoint-who-should-take-it/
[2] https://www.efesalud.com/esmo-2019-medir-beneficios-reales-medicamento-oncologico/
[2] https://endpts.com/bristol-myers-squibbs-opdivo-couldnt-topple-nexavar-in-hcc-but-will-better-safety-profile-win-over-physicians/
[2] https://endpts.com/esmo19-astrazeneca-heralds-tagrissos-os-lead-over-old-tkis-in-lung-cancer-niche/
[2] https://diagnostics.roche.com/global/en/events/esmo-2019.html?utm_campaign=esmo2019&utm_source=twitter&utm_medium=post&utm_term=&utm_content=rd:global:en:rms:lnk-events-geninfo
[2] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/tumore-del-polmone-raddoppiata-la-sopravvivenza-libera-da-progressione-esmo19.html
[2] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/tumori-cresce-la-spesa-per-i-farmaci-659-milioni-in-un-anno-esmo19.html
[2] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/tumore-polmone-nsclc-aumentata-la-sopravvivenza-dalla-prima-linea-con-atezolizumab-in-monoterapia-es.html
[2] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/tumori-con-fusione-genica-trk-con-larotrectinib-alto-tasso-di-risposte-durature-di-circa-3-anni-esmo.html
[2] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/tumore-del-pancreas-in-italia-6-di-nuovi-casi-in-5-anni-esmo19.html

Top URLs in Tweet in G9:
[5] https://www.roche.com/about/priorities/personalised-healthcare-cup.htm?utm_source=T&utm_medium=P&utm_campaign=GPS
[3] https://www.roche.com/media/releases/med-cor-2019-09-28.htm?utm_source=T&utm_medium=E&utm_campaign%20=ESMO19
[3] https://twitter.com/rocheitalia/status/1177626803709661185
[2] https://www.roche.com/media/releases/med-cor-2019-09-27.htm?utm_source=T&utm_medium=E&utm_campaign%20=ESMO19
[2] https://www.roche.com/media/releases/med-cor-2019-09-27b.htm?utm_source=T&utm_medium=E&utm_campaign%20=ESMO19
[2] https://www.roche.com/research_and_development/what_we_are_working_on/oncology/roche-at-esmo.htm?utm_source=T&utm_medium=E&utm_campaign=ESMO19
[2] https://www.sitcancer.org/research/cancer-immunotherapy-guidelines
[2] https://www.liberoquotidiano.it/news/salute/13509092/atezolizumab-ottimi-risultati-anche-senza-la-chemioterapia.html
[2] https://www.repubblica.it/oncologia/news/2019/09/25/news/esmo_2019_tradurre_la_scienza_in_cure_migliori_-236931032/
[1] https://www.roche.com/research_and_development/what_we_are_working_on/oncology/roche-at-esmo.htm?utm_source=T&utm_medium=E&utm_campaign=ESMO2019_ThoughtLeadership

Top URLs in Tweet in G10:
[5] https://wwwext.amgen.com/media/news-releases/2019/09/amgen-announces-new-clinical-data-evaluating-novel-investigational-krasg12c-inhibitor-in-patients-with-solid-tumors-at-esmo-2019/
[2] https://efpia.eu/about-medicines/use-of-medicines/disease-specific-groups/fighting-cancer/
[2] https://twitter.com/AndresC27622123/status/1177522782705504256
[2] https://wwwext.amgen.com/media/news-releases/2019/09/amgen-to-webcast-investor-call-at-esmo-2019/
[2] https://twitter.com/efpia/status/1177510773087563776
[1] http://r.socialstudio.radian6.com/e2165578-5de9-42d1-b44c-5f0453682f1f
[1] http://r.socialstudio.radian6.com/bb8aed23-05d1-4cb7-9f9a-00e27cb8b249
[1] http://r.socialstudio.radian6.com/6ddc0b88-7196-41bf-abc6-3e5ccb992cf6
[1] https://efpia.eu/we-wont-rest/connecting-healthcare/connecting-healthcare-projects/
[1] https://efpia.eu/we-wont-rest/patient-stories/?locId=0&orgId=0&diseaseId=11247

Top Domains
Top Domains in Tweet in Entire Graph:
[994] twitter.com
[232] esmo.org
[58] thelancet.com
[57] onclive.com
[56] instagram.com
[51] nejm.org
[45] statnews.com
[43] medscape.com
[36] evaluate.com
[32] saluteh24.com

Top Domains in Tweet in G1:
[575] twitter.com
[73] esmo.org
[52] instagram.com
[16] oncoinfo.it
[15] vjoncology.com
[13] nejm.org
[10] soundcloud.com
[9] bmj.com
[8] elsevierhealth.com
[8] jamanetwork.com

Top Domains in Tweet in G2:
[131] twitter.com
[39] onclive.com
[36] evaluate.com
[32] statnews.com
[29] esmo.org
[19] targetedonc.com
[15] nejm.org
[15] bms.com
[9] com.br
[8] thelancet.com

Top Domains in Tweet in G3:
[95] esmo.org
[79] twitter.com
[6] youtube.com
[6] bit.ly
[6] medscape.com
[6] immedicohospitalario.es
[5] medscape.org
[5] healthtechdigital.com
[4] doi.org
[4] diariomedico.com

Top Domains in Tweet in G4:
[96] twitter.com
[47] thelancet.com
[19] urotoday.com
[18] aacrjournals.org
[12] healio.com
[9] tiny.cc
[8] esmo.org
[8] mdanderson.org
[6] ac.uk
[5] oup.com

Top Domains in Tweet in G5:
[22] twitter.com
[11] nejm.org
[9] jamanetwork.com
[9] esmo.org
[2] ac.uk
[2] dana-farber.org
[2] mdanderson.org
[2] jax.org
[1] clinicaltrials.gov
[1] co.uk

Top Domains in Tweet in G6:
[6] twitter.com
[5] libtayo.com
[2] thepharmaletter.com
[1] bms.com
[1] oncology-central.com
[1] trinitylifesciences.com
[1] agendia.com

Top Domains in Tweet in G7:
[9] twitter.com
[8] nejm.org
[8] cancerresearch.org
[7] statnews.com
[5] fiercebiotech.com
[5] nature.com
[4] globenewswire.com
[3] loxooncology.com
[2] bbc.com
[2] esmo.org

Top Domains in Tweet in G8:
[21] twitter.com
[16] saluteh24.com
[12] linkedin.com
[9] endpts.com
[6] crweworld.com
[5] ilritrattodellasalute.org
[4] esmo.org
[4] medinews.it
[4] cancertherapyadvisor.com
[3] roche.com

Top Domains in Tweet in G9:
[15] roche.com
[6] twitter.com
[3] sitcancer.org
[3] liberoquotidiano.it
[3] repubblica.it
[2] ctimeetingtech.com
[2] esmo.org
[2] linkedin.com
[2] iqvia.com
[1] nanostring.com

Top Domains in Tweet in G10:
[8] amgen.com
[8] twitter.com
[8] saluteh24.com
[7] efpia.eu
[3] radian6.com
[3] gene.com
[1] globenewswire.com
[1] life-sciences-europe.com
[1] testyourcancer.com
[1] bayer.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[10110] esmo19
[2408] esmo2019
[1092] oncoalert
[757] lcsm
[657] immunotherapy
[608] cancer
[491] bcsm
[452] melanoma
[409] eons12
[328] oncology



Top Hashtags in Tweet in G1:
[4088] esmo19
[962] esmo2019
[662] oncoalert
[403] bcsm
[393] eons12
[368] cancer
[304] immunotherapy
[227] lcsm
[189] oncology
[131] strategy

Top Hashtags in Tweet in G2:
[2176] esmo19
[549] esmo2019
[426] lcsm
[264] oncoalert
[163] lungcancer
[96] immunotherapy
[77] melanoma
[64] nsclc
[47] barcelona
[41] ovariancancer

Top Hashtags in Tweet in G3:
[1141] esmo19
[241] esmo2019
[105] cancer
[82] oncoalert
[68] medscapelive
[62] oncology
[53] lcsm
[51] nsclc
[43] barcelona
[40] esmodaily

Top Hashtags in Tweet in G4:
[1089] esmo19
[221] esmo2019
[61] oncoalert
[61] ovariancancer
[58] rcc
[52] prostatecancer
[48] bladdercancer
[47] pcsm
[47] kidneycancer
[33] immunotherapy

Top Hashtags in Tweet in G5:
[230] esmo19
[79] ovariancancer
[73] esmo2019
[59] immunotherapy
[27] melanoma
[24] nsclc
[14] oncoalert
[12] lcsm
[8] prostatecancer
[8] pcsm

Top Hashtags in Tweet in G6:
[191] esmo19
[64] immunotherapy
[44] livercancer
[23] esmo2019
[19] esophagealcancer
[18] carcinoma
[17] squamous
[15] kidneycancer
[9] cancerresearch
[9] cholangiocarcinoma

Top Hashtags in Tweet in G7:
[143] esmo19
[133] melanoma
[25] esmo2019
[18] immunotherapy
[11] melanoom
[10] cicon19
[7] ovariancancer
[6] axlinhibitor
[5] bemcentinib
[4] lungcancer

Top Hashtags in Tweet in G8:
[146] esmo19
[85] esmo2019
[9] barcelona
[9] cancer
[9] esmo
[8] tumore
[6] cancro
[5] ovariancancer
[4] salute
[3] oncología

Top Hashtags in Tweet in G9:
[144] esmo19
[37] immunotherapy
[32] esmo2019
[26] ovariancancer
[23] dyk
[19] melanoma
[12] cham2019
[12] infirmiers
[10] cancer
[10] lungcancer

Top Hashtags in Tweet in G10:
[113] esmo19
[13] cancer
[12] wewontrest
[12] trkfusioncancer
[10] precisiononcology
[9] improvingcancercare
[7] carcinomaovarico
[7] news
[7] bayer
[7] precision

Top Words
Top Words in Tweet in Entire Graph:
[22453] Words in Sentiment List#1: Positive
[11009] Words in Sentiment List#2: Negative
[6] Words in Sentiment List#3: Angry/Violent
[466547] Non-categorized Words
[500009] Total Words
[15706] #esmo19
[3800] cancer
[3761] #esmo2019
[3391] patients
[3070] myesmo

Top Words in Tweet in G1:
[6285] #esmo19
[1647] gt
[1470] cancer
[1463] #esmo2019
[1310] #oncoalert
[1288] myesmo
[1222] patients
[852] oncoalert
[811] #cancer
[778] #bcsm

Top Words in Tweet in G2:
[3222] #esmo19
[923] #esmo2019
[819] #lcsm
[743] os
[726] cancer
[699] patients
[559] myesmo
[547] #oncoalert
[528] trial
[501] data

Top Words in Tweet in G3:
[1561] #esmo19
[628] myesmo
[418] cancer
[328] #esmo2019
[266] patients
[164] dr
[160] session
[157] poster
[151] #oncoalert
[142] trial

Top Words in Tweet in G4:
[2024] #esmo19
[493] trial
[467] adjuvant
[466] cancer
[447] results
[438] patients
[405] myesmo
[402] #esmo2019
[287] metastatic
[284] data

Top Words in Tweet in G5:
[552] #esmo19
[393] nivolumab
[369] ipilimumab
[347] patients
[301] alone
[271] 5
[271] year
[240] survival
[237] trial
[217] combination

Top Words in Tweet in G6:
[308] #esmo19
[142] more
[105] year
[98] diagnosed
[78] cancer
[70] kidney
[63] #immunotherapy
[63] people
[62] trace
[62] origin

Top Words in Tweet in G7:
[335] #esmo19
[240] yrs
[226] survive
[183] cancer
[163] patients
[157] 1
[156] combo
[150] advanced
[147] more
[144] now

Top Words in Tweet in G8:
[148] #esmo19
[85] #esmo2019
[34] cancer
[28] patients
[25] di
[18] esmo
[18] barcelona
[18] great
[18] more
[18] 3

Top Words in Tweet in G9:
[184] #esmo19
[58] cancer
[58] #esmo2019
[50] women
[45] important
[44] patient
[43] oncology
[42] #immunotherapy
[36] data
[35] latest

Top Words in Tweet in G10:
[183] #esmo19
[101] cancer
[54] more
[43] patients
[41] together
[38] #wewontrest
[37] new
[32] #improvingcancercare
[27] oncology
[26] find

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[1035] gt,gt
[587] #esmo19,#oncoalert
[559] #esmo19,myesmo
[554] pd,l1
[550] myesmo,#esmo19
[498] esmo19,insights
[498] insights,gt
[498] gt,published
[494] #esmo19,#followthepatient
[494] #followthepatient,#lucidquest

Top Word Pairs in Tweet in G1:
[1003] gt,gt
[492] esmo19,insights
[492] insights,gt
[492] gt,published
[488] #esmo19,#followthepatient
[488] #followthepatient,#lucidquest
[398] #esmo19,#oncoalert
[353] #eons12,#esmo19
[254] #esmo19,myesmo
[244] #esmo19,#bcsm

Top Word Pairs in Tweet in G2:
[313] #esmo19,#lcsm
[212] pd,l1
[160] nivo,ipi
[150] first,line
[129] hr,0
[123] #oncoalert,#lcsm
[106] myesmo,oncoalert
[105] myesmo,#esmo19
[103] lung,cancer
[96] overall,survival

Top Word Pairs in Tweet in G3:
[122] #esmo19,myesmo
[110] myesmo,#esmo19
[66] #esmo19,now
[66] now,live
[62] breast,cancer
[47] cancer,#esmo19
[45] first,line
[44] overall,survival
[44] thrombo,inflammation
[41] ovarian,cancer

Top Word Pairs in Tweet in G4:
[152] prostate,cancer
[124] myesmo,#esmo19
[119] presented,#esmo19
[118] #esmo2019,#esmo19
[108] meta,analysis
[105] adjuvant,vs
[102] metastatic,burden
[93] urotoday,#esmo2019
[89] biochemical,relapse
[89] 1st,line

Top Word Pairs in Tweet in G5:
[265] 5,year
[194] trial,#esmo19
[148] nivolumab,alone
[146] see,checkmate
[137] year,survival
[137] checkmate,067
[131] follow,up
[130] ipilimumab,alone
[129] 52,patients
[128] year,min

Top Word Pairs in Tweet in G6:
[70] kidney,cancer
[62] year,trace
[62] trace,origin
[62] origin,modern
[62] modern,#immunotherapy
[62] #immunotherapy,#esmo19
[55] learn,more
[41] #livercancer,incidence
[41] incidence,more
[41] more,tripled

Top Word Pairs in Tweet in G7:
[127] advanced,#melanoma
[118] nivo,ipi
[117] patients,advanced
[117] ipi,combo
[114] cancer,#immunotherapy
[113] 10,yrs
[113] yrs,ago
[113] ago,1
[113] 1,20
[113] 20,patients

Top Word Pairs in Tweet in G8:
[9] learn,more
[7] day,#esmo19
[7] anni,#esmo19
[6] bristol,myers
[6] #esmo,#esmo2019
[5] #esmo19,bristol
[5] lung,cancer
[5] breast,cancer
[5] 3,anni
[5] live,#esmo19

Top Word Pairs in Tweet in G9:
[25] patient,survival
[23] #dyk,estimated
[23] estimated,300
[23] 300,000
[23] 000,women
[23] women,diagnosed
[23] diagnosed,#ovariancancer
[23] #ovariancancer,year
[23] year,forums
[23] forums,#esmo19

Top Word Pairs in Tweet in G10:
[29] #esmo19,#improvingcancercare
[25] #improvingcancercare,#wewontrest
[18] taking,action
[18] action,cancer
[18] cancer,together
[18] cancer,care
[16] find,out
[15] out,more
[15] diagnosed,cancer
[14] new,data

Top Replied-To
Top Replied-To in Entire Graph:
@myesmo
@cancernurseeu
@anzuptrials
@geoff_oxnard
@weoncologists
@drsanjaypopat
@montypal
@tony_calles
@oncoinfo_it
@drchoueiri

Top Replied-To in G1:
@cancernurseeu
@myesmo
@weoncologists
@anzuptrials
@oncoinfo_it
@druryal
@ruthkilcawley
@drsanjaypopat
@profglongmia
@geoff_oxnard

Top Replied-To in G2:
@tony_calles
@jacobplieth
@drsanjaypopat
@renohemonc
@geoff_oxnard
@apassaromd
@doccatenacci
@bertrandbio
@ecastromarcos
@lauramezquitamd

Top Replied-To in G3:
@myesmo
@nreguart
@imaginabinc
@annals_oncology
@petitprez_f
@breastcancerorg
@kimtruss
@andresc27622123
@zymeworksinc
@who

Top Replied-To in G4:
@anzuptrials
@montypal
@neerajaiims
@soaresandrey
@cdncancertrials
@tommyrochmn
@prof_iand
@oncoblogg
@drchoueiri
@leitaomd

Top Replied-To in G5:
@eortc
@myesmo
@ramalingammd
@labsadanandam
@kgapo

Top Replied-To in G6:
@charityammf
@olofssonbagge
@dr_anna_ryan

Top Replied-To in G9:
@chrisheery
@jasonlukemd
@pateloncology
@jodebon
@markarubin1
@markpricedavies
@abcdiagnosis

Top Replied-To in G10:
@bayerpharma
@tobiashelmstorf
@geoff_oxnard
@genentech

Top Mentioned
Top Mentioned in Entire Graph:
@myesmo
@oncoalert
@cancernurseeu
@nejm
@peters_solange
@urotoday
@ramalingammd
@mocbrasil
@bettinaryll
@matteolambe

Top Mentioned in G1:
@myesmo
@oncoalert
@cancernurseeu
@matteolambe
@bettinaryll
@weoncologists
@who
@peters_solange
@metupukorg
@nejm

Top Mentioned in G2:
@myesmo
@oncoalert
@peters_solange
@ramalingammd
@winshipatemory
@nejm
@mocbrasil
@drsanjaypopat
@gustaveroussy
@astrazeneca

Top Mentioned in G3:
@myesmo
@vhio
@grupogetne
@oncoalert
@jhernando3
@hospitalclinic
@paulajfonseca
@ja_capdevila
@_seom
@anaoaknin

Top Mentioned in G4:
@myesmo
@urotoday
@oncoalert
@drchoueiri
@pcaparker
@mocbrasil
@montypal
@uromigos
@annals_oncology
@asco

Top Mentioned in G5:
@nejm
@royalmarsdennhs
@icr_london
@myesmo
@bopacommittee
@oncoalert
@jamaonc
@petaleighhughes
@ihme_uw
@pcaparker

Top Mentioned in G6:
@cca_alliance
@myesmo
@ccaukgroup
@charityammf
@sci_ed_support
@ccaens
@curecc
@acpuk
@incyte
@trinitylifesci

Top Mentioned in G7:
@cancerresearch
@myesmo
@natrevdrugdisc
@nejm
@oncoalert
@jonesannwen
@vmlucey
@juntangbiotech
@annie_yu_cri
@mayoclinic

Top Mentioned in G8:
@servieroncoarg

Top Mentioned in G9:
@myesmo
@nki_nl
@pascierto
@ipsosfrance
@ibmwatsonhealth
@fondmelanoma
@rdienstmann
@jhupath
@hartwigmedical
@bms_immunonc_us

Top Mentioned in G10:
@myesmo
@novartis
@bayerpharma
@amgen
@lungevity
@pfizer_france
@cci_europe
@cci_survivors
@bettinaryll
@pharmabe

Top Tweeters
Top Tweeters in Entire Graph:
@oldlady12345
@clarita_mate
@hrblock_21
@heelleclech
@inabster
@cronicas_diary
@onahunttoday
@repubblica
@soniaerasmus
@ramiro1504p

Top Tweeters in G1:
@lavanguardia
@mesonco
@nembotavy_0101
@breakingnewsie
@abcdiagnosis
@margymayell
@pash22
@caseofdees
@btkrth
@alisyngayle

Top Tweeters in G2:
@soniaerasmus
@threadreaderapp
@passarelliallan
@gambiste1
@pardoe_ai
@giacomomarcella
@sesiegler
@mogulazam
@youngchris27040
@wef

Top Tweeters in G3:
@cronicas_diary
@adnanserpen
@caring_mobile
@efenoticias
@levante_emv
@tomvarghesejr
@pilicanedo
@pinkmartina
@golorico
@btvnoticies

Top Tweeters in G4:
@galarole08
@omi_082
@nachodeferrol
@dailymailuk
@ebscbwi
@ene3112
@tigerlady100
@evidencerobot
@thecuriousluke
@ccprakay

Top Tweeters in G5:
@pvalsfr
@reporterphoenix
@saludhealthinfo
@mt_mae_tt
@wordfinga
@monitor_ph
@marymaryregan
@davidagoodland
@marciasgreen
@timallenmdjd

Top Tweeters in G6:
@oldlady12345
@clarita_mate
@hrblock_21
@inabster
@onahunttoday
@npsusa
@baronianconsult
@sba1211
@pegmeerkatz
@moveover4me2

Top Tweeters in G7:
@gofloors
@911noplaner
@infooverkanker
@pnani456
@realmaciej
@omicsomicsblog
@johncarlos
@rhcguy
@gpepmx
@how_to_coin

Top Tweeters in G8:
@saeedbaygi
@evalinadexter
@radiodiscapacid
@chris_chocobo
@stejar58
@hotteststocknow
@nevitdilmen
@mayflower014
@antoniocaperna
@neptunoroboto

Top Tweeters in G9:
@repubblica
@nightstock
@nchevesson
@ufuk89486848
@hope2casagem
@cinziasams
@data_danny_11
@weldeiry
@umich
@jeromeleleu

Top Tweeters in G10:
@thebayzdonyae
@signoraldo
@doranncecil
@sophieblack2016
@ladolcevitaone
@alohajosie
@francoleuzzi
@methos2010
@eduardoarmienta
@carrolla491


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.